Systemic therapy for duodenal adenocarcinoma: An analysis of the National Cancer Database (NCDB)
Author:
Kaslow Sarah R.,
Prendergast Katherine,
Vitiello Gerardo A.,
Hani LeenaORCID,
Berman Russell S.,
Lee Ann Y.,
Correa-Gallego Camilo
Reference26 articles.
1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019
2. Treatment and survival of small-bowel adenocarcinoma in the United States: a comparison with colon cancer;Young;Dis Colon Rectum,2016
3. Clinical outcomes of small bowel adenocarcinoma;Akce;Clin Colorect Cancer,2019
4. Small bowel adenocarcinomas: impact of location on survival;Lee;J Surg Res,2020
5. Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献